Determinants of fasting and post-methionine homocysteine levels in families predisposed to hyperhomocysteinemia and premature vascular disease

被引:24
作者
de Jong, SC
Stehouwer, CDA
van den Berg, M
Kostense, PJ
Alders, D
Jakobs, C
Pals, G
Rauwerda, JA
机构
[1] Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Inst Cardiovasc Res, NL-1081 HV Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Surg, Div Vasc Surg, NL-1081 HV Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Epidemiol & Biostat, NL-1081 HV Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Inst Res Extramural Med, NL-1081 HV Amsterdam, Netherlands
[6] Vrije Univ Amsterdam, Acad Ziekenhuis, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands
[7] Vrije Univ Amsterdam, Dept Anthropogenet, NL-1081 HV Amsterdam, Netherlands
关键词
homocysteine; methionine loading test methylenetetrahydrofolate reductase; vitamins; familial hyperhomocysteinemia; premature vascular disease;
D O I
10.1161/01.ATV.19.5.1316
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Elevated plasma total homocysteine (tHcy) levels, either measured in the fasting state or after oral methionine loading, are associated with an increased risk of atherothrombotic disease. Fasting and post-methionine hyperhomocysteinemia (HHC) overlap to a limited extent; both can occur as familial traits. We investigated determinants of fasting; postmethionine and delta (ie, post-methionine minus fasting levels) tHcy levels in 510 subjects of 192 HHC-prone families including 161 patients with clinical vascular disease and 349 without vascular disease. We focused on tHcy levels in relation to levels of vitamin B-12, B-6 and folate and the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Multivariate linear analyses adjusted for the presence of vascular disease showed that fasting tHcy was significantly related to folate and vitamin B-12, and the presence of the MTHFR TT genotype and the T allele, and to age, smoking habits, and serum levels of creatinine. Both post-methionine and delta tHcy levels were related to serum;folate levels, and the presence of the MTHFR TT genotype and the T allele, and to postmenopausal status, and body mass index. An interaction was found between MTHFR TT genotype and serum folate levels for both fasting and post-methionine tHcy, ie, for a:given decrease in serum folate, homocysteine levels increased more in subjects with the TT genotype than in those with the CC genotype. Fasting, post-methionine and delta tHcy were higher in patients with vascular disease than in their healthy siblings, but these levels were less dependent on serum folate levels (P < 0.05), whereas the effect of MTHFR genotype was stronger (P = 0.01). This-study found evidence that post-methionine and delta tHcy levels are not only influenced by factors affecting homocysteine transsulfuration but also by factors that affect: remethylation. explained variances of fasting, post-methionine and delta tHcy were 49%, 62%, and 78%, respectively. We also found evidence, in patients with premature vascular disease but not in their healthy siblings, for a factor that increases tHcy levels but weakens the normal inverse relation between folate and tHcy and amplifies the effect of the MTHFR genotype.
引用
收藏
页码:1316 / 1324
页数:9
相关论文
共 51 条
[1]   PLASMA HOMOCYSTEINE BEFORE AND AFTER METHIONINE LOADING WITH REGARD TO AGE, GENDER, AND MENOPAUSAL STATUS [J].
ANDERSSON, A ;
BRATTSTROM, L ;
ISRAELSSON, B ;
ISAKSSON, A ;
HAMFELT, A ;
HULTBERG, B .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (02) :79-87
[2]   Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over [J].
Bates, CJ ;
Mansoor, MA ;
vanderPols, J ;
Prentice, A ;
Cole, TJ ;
Finch, S .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 1997, 51 (10) :691-697
[3]   UNIQUE EFFICIENCY OF METHIONINE METABOLISM IN PREMENOPAUSAL WOMEN MAY PROTECT AGAINST VASCULAR-DISEASE IN THE REPRODUCTIVE YEARS [J].
BOERS, GH ;
SMALS, AG ;
TRIJBELS, FJ ;
LEERMAKERS, AI ;
KLOPPENBORG, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (06) :1971-1976
[4]   POST-METHIONINE LOAD HYPERHOMOCYSTEINEMIA IN PERSONS WITH NORMAL FASTING TOTAL PLASMA HOMOCYSTEINE - INITIAL RESULTS FROM THE NHLBI FAMILY HEART-STUDY [J].
BOSTOM, AG ;
JACQUES, PF ;
NADEAU, MR ;
WILLIAMS, RR ;
ELLISON, RC ;
SELHUB, J .
ATHEROSCLEROSIS, 1995, 116 (01) :147-151
[5]   Excess prevalence of fasting and postmethionine-loading hyperhomocysteinemia in stable renal transplant recipients [J].
Bostom, AG ;
Gohh, RY ;
Tsai, MY ;
HopkinsGarcia, BJ ;
Nadeau, MR ;
Bianchi, LA ;
Jacques, PF ;
Rosenberg, IH ;
Selhub, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (10) :1894-1900
[6]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[7]   IMPAIRED HOMOCYSTEINE METABOLISM IN EARLY-ONSET CEREBRAL AND PERIPHERAL OCCLUSIVE ARTERIAL-DISEASE - EFFECTS OF PYRIDOXINE AND FOLIC-ACID TREATMENT [J].
BRATTSTROM, L ;
ISRAELSSON, B ;
NORRVING, B ;
BERGQVIST, D ;
THORNE, J ;
HULTBERG, B ;
HAMFELT, A .
ATHEROSCLEROSIS, 1990, 81 (01) :51-60
[8]   HYPERHOMOCYSTEINAEMIA IN STROKE - PREVALENCE, CAUSE, AND RELATIONSHIPS TO TYPE OF STROKE AND STROKE RISK-FACTORS [J].
BRATTSTROM, L ;
LINDGREN, A ;
ISRAELSSON, B ;
MALINOW, MR ;
NORRVING, B ;
UPSON, B ;
HAMFELT, A .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (03) :214-221
[9]   A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction [J].
Brugada, R ;
Marian, AJ .
ATHEROSCLEROSIS, 1997, 128 (01) :107-112
[10]   Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease [J].
Christensen, B ;
Frosst, P ;
LussierCacan, S ;
Selhub, J ;
Goyette, P ;
Rosenblatt, DS ;
Genest, J ;
Rozen, R .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (03) :569-573